
Xuan Marian Thai
Supervisory Patent Examiner (ID: 11238, Phone: (571)272-7147 , Office: P/3715 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3403, 2111, 3713, 3715, 3714, 2781, 2181, 2782 |
| Total Applications | 777 |
| Issued Applications | 392 |
| Pending Applications | 173 |
| Abandoned Applications | 214 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5520896
[patent_doc_number] => 20090028877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Antibody Composition Specifically Binding to Ganglioside Gm'
[patent_app_type] => utility
[patent_app_number] => 10/575114
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 38007
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20090028877.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575114 | Antibody Composition Specifically Binding to Ganglioside Gm | Oct 7, 2004 | Abandoned |
Array
(
[id] => 4959677
[patent_doc_number] => 20080274102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Antibodies to Nik, Their Preparation and Use'
[patent_app_type] => utility
[patent_app_number] => 10/573136
[patent_app_country] => US
[patent_app_date] => 2004-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26425
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274102.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573136
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573136 | Antibodies to Nik, Their Preparation and Use | Oct 4, 2004 | Abandoned |
Array
(
[id] => 8675667
[patent_doc_number] => 08383781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'Anti-NIK antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/573138
[patent_app_country] => US
[patent_app_date] => 2004-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 27307
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10573138
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573138 | Anti-NIK antibodies and uses thereof | Oct 4, 2004 | Issued |
Array
(
[id] => 5188407
[patent_doc_number] => 20070166715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Diagnostics and therapeutics for diseases associated with aminopeptidase-like 1 (npepl1)'
[patent_app_type] => utility
[patent_app_number] => 10/575361
[patent_app_country] => US
[patent_app_date] => 2004-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 34454
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166715.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575361
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575361 | Diagnostics and therapeutics for diseases associated with aminopeptidase-like 1 (npepl1) | Oct 1, 2004 | Abandoned |
Array
(
[id] => 7202866
[patent_doc_number] => 20050042670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/954110
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 22160
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042670.pdf
[firstpage_image] =>[orig_patent_app_number] => 10954110
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/954110 | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | Sep 29, 2004 | Abandoned |
Array
(
[id] => 5182566
[patent_doc_number] => 20070053912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Compounds for neutralizing the effects of secreted pla2iia'
[patent_app_type] => utility
[patent_app_number] => 10/572875
[patent_app_country] => US
[patent_app_date] => 2004-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3326
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053912.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572875
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572875 | Compounds for neutralizing the effects of secreted pla2iia | Sep 21, 2004 | Abandoned |
Array
(
[id] => 5027990
[patent_doc_number] => 20070269437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Pro-Inflammatory and Anti-Inflammatory Antibodies Against the Heparin-Binding Protein (Hbp)'
[patent_app_type] => utility
[patent_app_number] => 10/572603
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13408
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269437.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572603 | Pro-Inflammatory and Anti-Inflammatory Antibodies Against the Heparin-Binding Protein (Hbp) | Sep 16, 2004 | Abandoned |
Array
(
[id] => 5624848
[patent_doc_number] => 20060263353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Methods for obtaining antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/568246
[patent_app_country] => US
[patent_app_date] => 2004-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10242
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263353.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568246
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568246 | Methods for obtaining antibodies | Aug 11, 2004 | Abandoned |
Array
(
[id] => 5050827
[patent_doc_number] => 20070031372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Vaccine immunotherapy for immune suppressed patients'
[patent_app_type] => utility
[patent_app_number] => 10/567320
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16022
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031372.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567320
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567320 | Vaccine immunotherapy for immune suppressed patients | Aug 4, 2004 | Abandoned |
Array
(
[id] => 806418
[patent_doc_number] => 07419665
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-02
[patent_title] => 'Monoclonal antibodies for detection of urinary trypsin inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/574862
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10079
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/419/07419665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10574862
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574862 | Monoclonal antibodies for detection of urinary trypsin inhibitors | Jul 28, 2004 | Issued |
Array
(
[id] => 5230339
[patent_doc_number] => 20070292446
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2007-12-20
[patent_title] => 'Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin'
[patent_app_type] => utility
[patent_app_number] => 10/561175
[patent_app_country] => US
[patent_app_date] => 2004-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3374
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0292/20070292446.pdf
[firstpage_image] =>[orig_patent_app_number] => 10561175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/561175 | Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin | Jun 21, 2004 | Abandoned |
Array
(
[id] => 5230339
[patent_doc_number] => 20070292446
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2007-12-20
[patent_title] => 'Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin'
[patent_app_type] => utility
[patent_app_number] => 10/561175
[patent_app_country] => US
[patent_app_date] => 2004-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3374
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0292/20070292446.pdf
[firstpage_image] =>[orig_patent_app_number] => 10561175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/561175 | Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin | Jun 21, 2004 | Abandoned |
Array
(
[id] => 5608034
[patent_doc_number] => 20060269550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Anti-ghrelin fab antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/558604
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17017
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269550.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558604
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558604 | Anti-ghrelin fab antibodies | May 27, 2004 | Abandoned |
Array
(
[id] => 4497378
[patent_doc_number] => 07919089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-05
[patent_title] => 'Pharmaceutical composition comprising a bispecific antibody for EpCAM'
[patent_app_type] => utility
[patent_app_number] => 10/554851
[patent_app_country] => US
[patent_app_date] => 2004-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 45
[patent_no_of_words] => 18648
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/919/07919089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554851
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554851 | Pharmaceutical composition comprising a bispecific antibody for EpCAM | May 25, 2004 | Issued |
Array
(
[id] => 5834689
[patent_doc_number] => 20060246520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Gamma delta t cell-mediated therapy'
[patent_app_type] => utility
[patent_app_number] => 10/558110
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9581
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246520.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558110
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558110 | Gamma delta t cell-mediated therapy | May 18, 2004 | Abandoned |
Array
(
[id] => 5784474
[patent_doc_number] => 20060204565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Conjugates and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/552569
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6087
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204565.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552569
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552569 | Conjugates and use thereof | May 5, 2004 | Abandoned |
Array
(
[id] => 5000314
[patent_doc_number] => 20070042948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Vav inhibition in graft rejection'
[patent_app_type] => utility
[patent_app_number] => 10/552836
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9474
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552836
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552836 | Vav inhibition in graft rejection | Apr 14, 2004 | Abandoned |
Array
(
[id] => 5004529
[patent_doc_number] => 20070202097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Monoclonal Antibodies That Recognise Mucosal Addressin Cell Adhesion Molecule-1 (Madcam-1), Soluble Madcam-1 And Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/548390
[patent_app_country] => US
[patent_app_date] => 2004-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14192
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548390
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548390 | Monoclonal Antibodies That Recognise Mucosal Addressin Cell Adhesion Molecule-1 (Madcam-1), Soluble Madcam-1 And Uses Thereof | Mar 9, 2004 | Abandoned |
Array
(
[id] => 5720742
[patent_doc_number] => 20060073517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Post-translational modifications of proteins as regulatory switches'
[patent_app_type] => utility
[patent_app_number] => 10/548747
[patent_app_country] => US
[patent_app_date] => 2004-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11186
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073517.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548747
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548747 | Post-translational modifications of proteins as regulatory switches | Mar 8, 2004 | Abandoned |
Array
(
[id] => 8293976
[patent_doc_number] => 08221758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-17
[patent_title] => 'Anti-midkine antibody for preventing post-laparotomy adhesions'
[patent_app_type] => utility
[patent_app_number] => 10/547011
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5731
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10547011
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547011 | Anti-midkine antibody for preventing post-laparotomy adhesions | Mar 4, 2004 | Issued |